Bio-Path Holdings, Inc. (BPTH)
0.0257
0.00 (0.00%)
USD |
OTCM |
Sep 09, 16:00
Bio-Path Holdings Enterprise Value : 1.812M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 1.812M |
| September 08, 2026 | 1.812M |
| September 04, 2026 | 1.812M |
| September 03, 2026 | 1.274M |
| September 02, 2026 | 1.525M |
| September 01, 2026 | 1.701M |
| August 31, 2026 | 1.827M |
| August 28, 2026 | 1.827M |
| August 27, 2026 | 2.028M |
| August 26, 2026 | 2.028M |
| August 25, 2026 | 2.128M |
| August 24, 2026 | 2.184M |
| August 21, 2026 | 2.229M |
| August 20, 2026 | 2.316M |
| August 19, 2026 | 2.316M |
| August 18, 2026 | 2.204M |
| August 17, 2026 | 2.058M |
| August 14, 2026 | 2.561M |
| August 13, 2026 | 2.279M |
| August 12, 2026 | 2.290M |
| August 11, 2026 | 2.400M |
| August 10, 2026 | 2.400M |
| August 07, 2026 | 2.405M |
| August 06, 2026 | 2.808M |
| August 05, 2026 | 2.430M |
| Date | Value |
|---|---|
| August 04, 2026 | 2.430M |
| August 03, 2026 | 2.430M |
| July 31, 2026 | 2.430M |
| July 30, 2026 | 2.732M |
| July 29, 2026 | 2.732M |
| July 28, 2026 | 2.732M |
| July 27, 2026 | 2.531M |
| July 24, 2026 | 2.531M |
| July 23, 2026 | 2.430M |
| July 22, 2026 | 2.430M |
| July 21, 2026 | 2.430M |
| July 20, 2026 | 2.430M |
| July 17, 2026 | 2.430M |
| July 16, 2026 | 2.468M |
| July 15, 2026 | 2.279M |
| July 14, 2026 | 2.667M |
| July 13, 2026 | 2.279M |
| July 10, 2026 | 2.279M |
| July 09, 2026 | 2.310M |
| July 08, 2026 | 2.531M |
| July 07, 2026 | 2.430M |
| July 06, 2026 | 2.833M |
| July 02, 2026 | 2.883M |
| July 01, 2026 | 2.279M |
| June 30, 2026 | 2.883M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.44B |
| Oncolytics Biotech, Inc. | 95.42M |
| Sangamo Therapeutics, Inc. | 55.96M |
| Sarepta Therapeutics, Inc. | 2.583B |
| Anixa Biosciences, Inc. | 82.91M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.636M |
| Total Expenses (Quarterly) | 2.636M |
| EPS Diluted (Quarterly) | -0.0875 |
| Earnings Yield | -1.00K% |
| Normalized Earnings Yield | -703.50 |